Stocks and Investing Stocks and Investing
Mon, November 15, 2021
Fri, November 12, 2021

Josh Beck Maintained (BLND) at Buy with Decreased Target to $16 on, Nov 12th, 2021


Published on 2024-10-27 18:38:35 - WOPRAI, Josh Beck
  Print publication without navigation


Josh Beck of Keybanc, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $22 to $16 on, Nov 12th, 2021.

Josh has made no other calls on BLND in the last 4 months.



There are 8 other peers that have a rating on BLND. Out of the 8 peers that are also analyzing BLND, 1 agrees with Josh's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Karl Keirstead of "UBS" Initiated at Hold and Held Target at $20 on, Tuesday, August 10th, 2021


These are the ratings of the 7 analyists that currently disagree with Josh


  • Arvind Ramnani of "Piper Sandler" Maintained at Buy with Decreased Target to $19 on, Thursday, November 11th, 2021
  • Bhavan Suri of "William Blair" Initiated at Buy on, Tuesday, August 10th, 2021
  • Joseph Vafi of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $28 on, Tuesday, August 10th, 2021
  • Justin Patterson of "Piper Sandler" Initiated at Buy and Held Target at $24 on, Tuesday, August 10th, 2021
  • Michael Ng of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Tuesday, August 10th, 2021
  • Michael Turrin of "Wells Fargo" Initiated at Buy and Held Target at $24 on, Tuesday, August 10th, 2021
  • Terry Tillman of "Truist Securities" Initiated at Strong Buy and Held Target at $24 on, Tuesday, August 10th, 2021
Contributing Sources